Tricyclic cell-penetrating peptides for efficient delivery of functional antibodies into cancer cells
- PMID: 35145246
- PMCID: PMC7617065
- DOI: 10.1038/s41557-021-00866-0
Tricyclic cell-penetrating peptides for efficient delivery of functional antibodies into cancer cells
Abstract
The intracellular environment hosts a large number of cancer- and other disease-relevant human proteins. Targeting these with internalized antibodies would allow therapeutic modulation of hitherto undruggable pathways, such as those mediated by protein-protein interactions. However, one of the major obstacles in intracellular targeting is the entrapment of biomacromolecules in the endosome. Here we report an approach to delivering antibodies and antibody fragments into the cytosol and nucleus of cells using trimeric cell-penetrating peptides (CPPs). Four trimers, based on linear and cyclic sequences of the archetypal CPP Tat, are significantly more potent than monomers and can be tuned to function by direct interaction with the plasma membrane or escape from vesicle-like bodies. These studies identify a tricyclic Tat construct that enables intracellular delivery of functional immunoglobulin-G antibodies and Fab fragments that bind intracellular targets in the cytosol and nuclei of live cells at effective concentrations as low as 1 μM.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.
Conflict of interest statement
The authors declare no competing interests.
Figures
Comment in
-
Peptides as molecular Trojan horses.Nat Chem. 2022 Mar;14(3):250-252. doi: 10.1038/s41557-022-00906-3. Nat Chem. 2022. PMID: 35228689 No abstract available.
References
-
- Carter PJ, Lazar GA. Next generation antibody drugs: pursuit of the ‘high-hanging fruit’. Nature Reviews Drug Discovery. 2018;17:197–223. - PubMed
-
- Verdine GL, Walensky LD. The challenge of drugging undruggable targets in cancer: lessons learned from targeting BCL-2 family members. Clin Cancer Res. 2007;13:7264–7270. - PubMed
-
- Stewart MP, et al. In vitro and ex vivo strategies for intracellular delivery. Nature. 2016;538:183–192. - PubMed
-
- Samal SK, et al. Cationic polymers and their therapeutic potential. Chem Soc Rev. 2012;41:7147–7194. - PubMed
-
- Brooks H, Lebleu B, Vivès E. Tat peptide-mediated cellular delivery: back to basics. Adv Drug Del Rev. 2005;57:559–577. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
